多肽CRDMO平台
目录肽
中肽生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
PAP-003A
Protease-Activated Receptor-2, PAR-2 Agonist, amide
Ser-Leu-Ile-Gly-Lys-Val-NH2
Ser-Leu-Ile-Gly-Lys-Val-NH2
Size：1.0
P1(RMB)：153
MW：614.8
One letter sequence：SLIGKV-NH2
Molecular Formula：C28H54N8O7
Description：This protease-activated receptor activating peptide (PAR-2-AP) corresponds to the PAR2 tethered ligand. It can also be utlized to study the functions of receptors.
Literature Reference：Dulon et al. Am. J. Resp. Cell Mol. Biol. 28, 339 (2003); \nKim, M. et al. Cell Biochem. Funct. 20, 339 (2002); \nVesey, D. et al. Kidney International 67, 1315 (2005); \nHollenberg, M. Can. J. Physiol. Pharmacol. 75, 832 (1997); \nNishikawa, H. et al. J. Pharmacol. Exp. Ther. 312, 324 (2005).
Cas：
P1(RMB)：153
MW：614.8
One letter sequence：SLIGKV-NH2
Molecular Formula：C28H54N8O7
Description：This protease-activated receptor activating peptide (PAR-2-AP) corresponds to the PAR2 tethered ligand. It can also be utlized to study the functions of receptors.
Literature Reference：Dulon et al. Am. J. Resp. Cell Mol. Biol. 28, 339 (2003); \nKim, M. et al. Cell Biochem. Funct. 20, 339 (2002); \nVesey, D. et al. Kidney International 67, 1315 (2005); \nHollenberg, M. Can. J. Physiol. Pharmacol. 75, 832 (1997); \nNishikawa, H. et al. J. Pharmacol. Exp. Ther. 312, 324 (2005).
Cas：
